Moreover, thiazolidinediones such as rosiglitazone have been shown to reduce endothelial RAGE expression in patients with diabetes,41 suggesting a possible feedback loop in our model, as we demonstrated that RAGE is an upstream mediator of PPARγ. This evidence concerns the gene PPARG and diabetes mellitus.